Skyway pedestrians in Minneapolis can earn $100 for samples of their blood, urine and saliva in the latest type of genetic research, this time to help develop life insurance products.
Scientific Testing Partners, which set up in the second floor of the U.S. Bank building at the start of October, is seeking 1,000 participants in a project that illustrates the rapid expanse in genetic know-how and in its collection of data for business, public health, genealogy and academic research.
"This was a great place to get a cross section of people," said Dan Callahan, a spokesman for Scientific Testing, as lunchtime walkers cruised past Wednesday.
Such mass collection of genetic information for research has come a long way since the mapping of the human genome in 2003.
The Mayo Clinic is participating in the federal All Of Us project to collect genetic data and biospecimens from 1 million people to identify how genes, lifestyle choices and environment affect health. The University of Minnesota has collected saliva and lifestyle data from visitors at the State Fair to study influences on child development.
The genealogy company 23andMe has frequently provided anonymous genetic data to researchers and pharmaceutical companies and conducted its own studies. In 2015, it published a report in an academic journal on the genetic origins of motion sickness.
"It is important to democratize personal genetics and make it more accessible," 23andMe co-founder Anne Wojcicki said in a recent news release.
Now, this type of data collection is being adopted by the insurance industry, but in a way that prompted a buyer beware warning from the Minnesota Department of Commerce, because it provides no legal oversight over how that genetic data can be used.